Skip to content
2000
Volume 4, Issue 1
  • ISSN: 1574-8847
  • E-ISSN: 2212-3938

Abstract

Obesity is considered a worldwide epidemic. Weight reduction by means of lifestyle changes is difficult to achieve, and pharmacotherapy is frequently needed. Although all currently approved anti-obesity agents have proven to be effective to achieve some degree of weight reduction and improve cardiometabolic risk factors, different compounds differ in their mechanism of action and safety profile. However, it is still difficult to achieve and maintain therapeutic objectives along time. The aim of the present article is to summarize the main characteristics of available anti-obesity agents and to explore novel agents that may provide significant clinical benefits in the future.

Loading

Article metrics loading...

/content/journals/ccp/10.2174/157488409787236128
2009-01-01
2025-05-20
Loading full text...

Full text loading...

/content/journals/ccp/10.2174/157488409787236128
Loading

  • Article Type:
    Research Article
Keyword(s): Anti-obesity agents; obesity; orlistat; pharmacotherapy; rimonabant; sibutramine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test